Proteomic profiling of Myc-associated proteins, Cell Cycle, vol.9, pp.4908-4921, 2010. ,
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice, J. Clin. Invest, vol.120, pp.4129-4140, 2010. ,
Neoplastic disease after liver transplantation: focus on de novo neoplasms, World J. Gastroenterol, vol.21, pp.8753-8768, 2015. ,
, , 2003.
, N. Engl. J. Med, vol.348, pp.1625-1638
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis, Gastroenterology, vol.137, pp.1816-1826, 2009. ,
Curing chronic hepatitis C-the arc of a medical triumph, N. Engl. J. Med, vol.370, pp.1576-1578, 2014. ,
Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?, J. Gastrointest. Surg, vol.11, pp.1634-1639, 2007. ,
, , 2014.
, Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebocontrolled trial, Lancet, vol.383, pp.1041-1048
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States, Hepatology, vol.52, pp.132-141, 2010. ,
Statistical Methods for Research Workers, 1932. ,
Hepatocellular carcinoma, Lancet, vol.379, pp.1245-1255, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01134844
Differences in surgical outcomes between hepatitis B-and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center, Ann. Surg, vol.260, pp.650-658, 2014. ,
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma, Hepatology, vol.59, pp.1577-1590, 2014. ,
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology, Oncogene, vol.25, pp.1125-1142, 2006. ,
Gene expression in fixed tissues and outcome in hepatocellular carcinoma, N. Engl. J. Med, vol.359, 1995. ,
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis, Gastroenterology, vol.144, pp.1024-1030, 2013. ,
, , 2014.
, Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma, J. Hepatol, vol.61, pp.79-90
Regulation of hepatic stellate cells by connective tissue growth factor, Front Biosci, vol.17, pp.2495-2507, 2012. ,
Histological grading and staging of chronic hepatitis, J. Hepatol, vol.22, pp.696-699, 1995. ,
Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease, Inflamm. Bowel Dis, vol.11, pp.314-321, 2005. ,
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis, J. Gastroenterol, vol.44, pp.1190-1194, 2009. ,
Lysophospholipid receptors in drug discovery, Exp. Cell Res, vol.333, pp.171-177, 2015. ,
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration, Gut, vol.64, pp.1296-1302, 2015. ,
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT), JAMA, vol.301, pp.39-51, 2009. ,
Antifibrotic therapies in the liver, Semin. Liver Dis, vol.35, pp.184-198, 2015. ,
Comparison of improved prognosis between hepatitis B-and hepatitis C-related hepatocellular carcinoma, Hepatol. Res, vol.45, pp.99-107, 2015. ,
Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies, Ann. Intern. Med, vol.158, pp.329-337, 2013. ,
Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma, Cancer Res, vol.73, pp.4722-4731, 2013. ,
Autotaxin as a novel serum marker of liver fibrosis, Clin. Chim. Acta, vol.412, pp.1201-1206, 2011. ,
LPA1 receptor activation promotes renal interstitial fibrosis, J. Am. Soc. Nephrol, vol.18, pp.3110-3118, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409718
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation, FASEB J, vol.27, pp.1830-1846, 2013. ,
Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo, J. Biol. Chem, vol.279, pp.42169-42181, 2004. ,
Multiscale embedded gene Co-expression network analysis, PLoS Comput. Biol, vol.11, 2015. ,
, , 2015.
, Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding, Mol. Pharmacol, vol.88, pp.982-992
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, vol.102, pp.15545-15550, 2005. ,
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist, J. Pharmacol. Exp. Ther, vol.336, pp.693-700, 2011. ,
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis, Nat. Med, vol.14, pp.2584-2593, 2008. ,
Cancer genome landscapes, Science, vol.339, pp.1546-1558, 2013. ,
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C, J. Clin. Gastroenterol, vol.41, pp.616-623, 2007. ,
Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma, Cancer Lett, vol.275, pp.277-284, 2009. ,
, , 2016.
, A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection, Gut, vol.65, pp.1754-1764